BB-101
Asset
Promotes wound healing and tissue repair in diabetic ulcers.
- Stage
- Phase 2
- Modality
- Protein or enzyme
- Target
- Not known
- 1
- Indication
- 1
- Trial
- 1
- Developer
Indications
1Diabetic foot ulcer
Phase 2, Recruiting, NCT06383013, clinicaltrials.gov, 7 Oct 2026
In the full profile
- Owner and partners1
- Trials1
Every asset’s record: target, stage, trials and the evidence behind it.